Showing results (101-110 of 236) with videos related to

Sort By:
Pageof 24
Infectious Disease Clinics of North America|May 22, 2016
Agents of Last Resort: Polymyxin ResistanceKeith S Kaye, Jason M Pogue, Thien B Tran, et al.
The Journal of Antimicrobial Chemotherapy|April 10, 2024
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infectionsWalaiporn Wangchinda, Jason M Pogue, Visanu Thamlikitkul, et al.
Microbiology Spectrum|May 31, 2022
A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute BreakpointsVikas Gupta, Kalvin C Yu, Jason M Pogue, et al.
Infection and Drug Resistance|September 27, 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i>Lindsay A Petty, Oryan Henig, Twisha S Patel, et al.
Journal of Clinical Microbiology|March 7, 2014
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing methodDror Marchaim, Jason M Pogue, Oran Tzuman, et al.
Infectious Diseases and Therapy|July 20, 2020
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 CloneJohn P Mills, Keith S Kaye, Richard Evans, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii InfectionsRuthy Tal-Jasper, David E Katz, Nadav Amrami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative OrganismsArsheena Yassin, Mariya Huralska, Jason M Pogue, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2018
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic modelKatie E Barber, Jason M Pogue, Henderson D Warnock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical CenterJason M Pogue, Anupama Neelakanta, Ryan P Mynatt, et al.
Pageof 24